Ergoteles LLC Alnylam Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $3.93 Million - $5.52 Million	32,636 New	32,636 $4.76 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $1.5 Million - $1.83 Million	-8,811 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $1.13 Million - $1.56 Million	8,811 New	8,811 $1.49 Million
Q4 2020 Feb 11, 2021	SELL	$122.97 - $147.0 $3.16 Million - $3.77 Million	-25,661 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $3.11 Million - $4.25 Million	25,661 New	25,661 $3.74 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.